Signals / 13 Feb 2026

The morning briefing, 13 Feb 2026.

Bullish 13 Feb 2026 41 articles read · 8 sources

Performance art just got the blue-chip treatment. Florentina Holzinger—whose radical theatrical work has been polarizing audiences—joins Thaddaeus Ropac's international program, marking a watershed moment for performance-based practices entering the traditional gallery market. Meanwhile, Roy Lichtenstein's market is showing no signs of cooling: Gagosian is scheduling a 'Brushstroke' exhibition on the heels of $150M in recent auction activity and just ahead of the Whitney retrospective. That's the classic institutional validation cluster that historically precedes 12-24 month price appreciation windows. And watch Dread Scott—the censorship controversy at University of Maryland is creating exactly the visibility spike that tends to precede renewed collector interest in politically charged work.

Institutional validation is accelerating across tiers, from performance art entering blue-chip galleries to Growth-tier artists gaining Carnegie and censorship-driven visibility

The signals

6 on record
Strength 6

Performance artist Florentina Holzinger joins Thaddaeus Ropac gallery following Venice Biennale representation, signaling institutional validation for radical performance-based practices entering traditional gallery market

Gallery move to established international program (Ropac operates London, Paris, Salzburg) suggests tier upgrade trajectory from Growth to Value—rare opportunity to position ahead of institutional performance art segment expansion

gallery move · Growth · Florentina Holzinger
Strength 8

Gagosian scheduling Lichtenstein 'Brushstroke' exhibition following $150M auction run and ahead of Whitney retrospective—timing cluster of major gallery show, blue-chip retrospective, and strong auction performance

Whitney retrospectives historically precede 12-24 month price appreciation windows for Blue-chip artists—current holdings benefit from validation cluster, but entry prices now reflect institutional momentum

retrospective · Blue-chip · Roy Lichtenstein
Strength 6

Dread Scott excluded from University of Maryland exhibition amid institutional censorship controversy over flag-reinterpretation works, creating visibility spike around politically charged practice

Censorship controversies historically precede 6-12 month windows of increased collector and institutional interest in affected artists' provocative works—acquire before secondary market repricing

artist milestone · Value · Dread Scott
Strength 8

Henry Moore sculpture valued at £15M to headline Christie's 20th/21st Century Evening Sale in London, with vice chairman calling it 'the most exciting sculpture I've ever seen brought to market'

Exceptional quality positioning in evening sale validates continued strength in Moore's market—monitor hammer price for blue-chip modern sculpture segment health indicator

auction record · Blue-chip · Henry Moore
Strength 7

Amy Sherald solo exhibition breaks attendance records, indicating peak visibility and strong collector and institutional interest for this Value-tier artist

Record attendance validates continued market momentum and suggests strong secondary market support—current holdings well-positioned, but peak visibility may limit upside from new acquisitions

retrospective · Value · Amy Sherald
Strength 6

Jacqueline de Jong major survey exhibition at Kunstmuseum St. Gallen (September 2025-March 2026) provides institutional validation for historically undervalued Situationist artist with six-month duration at established Swiss institution

Extended institutional visibility window for Situationist artist offers rare acquisition opportunity in undervalued segment before broader market recognition—sustained curatorial interest signals reappraisal momentum

retrospective · Value · Jacqueline de Jong

Rising attention

Momentum
Florentina Holzinger Dread Scott Jacqueline de Jong Jasleen Kaur

Every morning, weighed for you.

Members get the full briefing — each signal measured against their own holdings, taste, and budget.

Try the live demo Join the waitlist

Egon Labs, Inc. · MMXXVI

Advisors · Partners · Manifesto · Signals · The Egon 100 · Contact · Terms · Privacy